Drugs / Th2 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001830 | Jul 1999 → May 2015 | B-cell chronic lymphocytic leukemia, Hodgkins lymphoma, graft versus host disease, plasma cell myeloma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Th2 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001830 ↗ |